ACCURAY INCORPORATED Income (Loss) from Equity Method Investments
ACCURAY INCORPORATED (ARAY) reported Income (Loss) from Equity Method Investments of $1.12 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-27
- ACCURAY INCORPORATED income (loss) from equity method investments for the quarter ending 2026-06-30 was -$194.00K, a 121.92% decline year-over-year.
- ACCURAY INCORPORATED income (loss) from equity method investments for the quarter ending 2026-03-31 was $408.00K, a 82.24% decline year-over-year.
- ACCURAY INCORPORATED income (loss) from equity method investments for the quarter ending 2025-12-31 was $471.00K, a 70.64% decline year-over-year.
- ACCURAY INCORPORATED income (loss) from equity method investments for the quarter ending 2025-09-30 was $439.00K.
- ACCURAY INCORPORATED income (loss) from equity method investments for fiscal 2026 was $1.12M, a 76.16% decline from fiscal 2025.
- ACCURAY INCORPORATED income (loss) from equity method investments for fiscal 2025 was $4.71M, a 156.47% increase from fiscal 2024.
- ACCURAY INCORPORATED income (loss) from equity method investments for fiscal 2024 was $1.84M, a 28.54% decline from fiscal 2023.
- ACCURAY INCORPORATED income (loss) from equity method investments for fiscal 2023 was $2.57M, a 967.22% increase from fiscal 2022.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $214.00K derived: sum of 2 quarters · filed 2026-08-27 | $685.00K derived: sum of 3 quarters · filed 2026-08-27 | $1.12M 10-K · filed 2026-08-27 | |
| 2026-03-31 | $408.00K 10-Q · filed 2026-05-06 | $879.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.32M 10-Q · filed 2026-05-06 | $2.20M derived: sum of 4 quarters · filed 2026-08-27 | |
| 2025-12-31 | $471.00K 10-Q · filed 2026-02-17 | $910.00K 10-Q · filed 2026-02-17 | $1.79M derived: sum of 3 quarters · filed 2026-08-27 | $4.09M derived: sum of 4 quarters · filed 2026-08-27 | |
| 2025-09-30 | $439.00K 10-Q/A · filed 2026-02-17 | $1.32M derived: sum of 2 quarters · filed 2026-08-27 | $3.62M derived: sum of 3 quarters · filed 2026-08-27 | $5.22M derived: sum of 4 quarters · filed 2026-08-27 | |
| 2025-06-30 | $885.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $3.18M derived: sum of 2 quarters · filed 2026-08-27 | $4.79M derived: sum of 3 quarters · filed 2026-08-27 | $4.71M 10-K · filed 2026-08-27 | |
| 2025-03-31 | $2.30M 10-Q · filed 2026-05-06 | $3.90M derived: sum of 2 quarters · filed 2026-05-06 | $3.83M 10-Q · filed 2026-05-06 | $4.64M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $1.60M 10-Q · filed 2026-02-17 | $1.53M 10-Q · filed 2026-02-17 | $2.34M derived: sum of 3 quarters · filed 2026-02-17 | $3.37M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | -$72.00K 10-Q/A · filed 2026-02-17 | $738.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.76M derived: sum of 3 quarters · filed 2026-02-17 | $1.33M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $810.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-02-17 | $1.83M derived: sum of 2 quarters · filed 2026-02-17 | $1.41M derived: sum of 3 quarters · filed 2026-02-17 | $1.84M 10-K/A · filed 2026-02-17 | |
| 2024-03-31 | $1.02M 10-Q · filed 2025-05-02 | $597.00K derived: sum of 2 quarters · filed 2025-05-02 | $1.03M 10-Q · filed 2025-05-02 | $2.64M derived: sum of 4 quarters · filed 2025-05-02 | |
| 2023-12-31 | -$427.00K 10-Q · filed 2025-02-05 | $4.00K 10-Q · filed 2025-02-05 | $1.62M derived: sum of 3 quarters · filed 2025-02-05 | $3.64M derived: sum of 4 quarters · filed 2025-02-05 | |
| 2023-09-30 | $431.00K 10-Q · filed 2024-11-06 | $2.04M derived: sum of 2 quarters · filed 2024-11-06 | $4.07M derived: sum of 3 quarters · filed 2024-11-06 | $3.37M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $3.64M derived: sum of 2 quarters · filed 2024-09-19 | $2.94M derived: sum of 3 quarters · filed 2024-09-19 | $2.57M 10-K · filed 2024-09-19 | |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-08 | $1.33M derived: sum of 2 quarters · filed 2024-05-08 | $960.00K 10-Q · filed 2024-05-08 | $427.00K derived: sum of 4 quarters · filed 2024-09-19 | |
| 2022-12-31 | -$699.00K 10-Q · filed 2024-02-07 | -$1.07M 10-Q · filed 2024-02-07 | -$1.60M derived: sum of 3 quarters · filed 2024-09-19 | $346.00K derived: sum of 4 quarters · filed 2024-09-19 | |
| 2022-09-30 | -$368.00K 10-Q · filed 2023-11-07 | -$901.00K derived: sum of 2 quarters · filed 2024-09-19 | $1.04M derived: sum of 3 quarters · filed 2024-09-19 | $213.00K derived: sum of 4 quarters · filed 2024-09-19 | |
| 2022-06-30 | -$533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $1.41M derived: sum of 2 quarters · filed 2024-09-19 | $581.00K derived: sum of 3 quarters · filed 2024-09-19 | $241.00K 10-K · filed 2024-09-19 | |
| 2022-03-31 | $1.95M 10-Q · filed 2023-05-08 | $1.11M derived: sum of 2 quarters · filed 2023-05-08 | $774.00K 10-Q · filed 2023-05-08 | $625.00K derived: sum of 4 quarters · filed 2023-09-07 | |
| 2021-12-31 | -$832.00K 10-Q · filed 2023-02-02 | -$1.17M 10-Q · filed 2023-02-02 | -$1.32M derived: sum of 3 quarters · filed 2023-09-07 | -$1.39M derived: sum of 4 quarters · filed 2023-09-07 | |
| 2021-09-30 | -$340.00K 10-Q · filed 2022-11-03 | -$489.00K derived: sum of 2 quarters · filed 2023-09-07 | -$557.00K derived: sum of 3 quarters · filed 2023-09-07 | $560.00K derived: sum of 4 quarters · filed 2023-09-07 | |
| 2021-06-30 | -$149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-07 | -$217.00K derived: sum of 2 quarters · filed 2023-09-07 | $900.00K derived: sum of 3 quarters · filed 2023-09-07 | $872.00K 10-K · filed 2023-09-07 | |
| 2021-03-31 | -$68.00K 10-Q · filed 2022-04-29 | $1.05M derived: sum of 2 quarters · filed 2022-04-29 | $1.02M 10-Q · filed 2022-04-29 | ||
| 2020-12-31 | $1.12M 10-Q · filed 2022-01-28 | $1.09M 10-Q · filed 2022-01-28 | |||
| 2020-06-30 | -$13.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-17 | -$13.11M derived: sum of 2 quarters · filed 2022-08-17 | -$149.00K 10-K · filed 2022-08-17 | $12.96M 10-K · filed 2020-08-25 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-30 | $12.96M 10-Q · filed 2021-04-30 | |||
| 2019-12-31 | $12.96M 10-Q · filed 2021-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |